Updated 15 hours ago
Kebbi3 receives Japanese care-technology classification

Kebbi3 receives Japanese care-technology classification

Marubun’s October 29 announcement concerns a care‑technology listing for the AI communication robot. Its TAIS identifier helps buyers check the listed equipment; it does not establish an individual funding award.

Match the listing to the equipment being considered

Marubun’s October 29 announcement says Kebbi3 was selected as care technology in the monitoring‑and‑communication category. The distributor describes this as meeting one criterion relevant to subsidy support, rather than reporting an award to a particular facility.

The TAIS registry entry identifies Kebbi3 as model AIR‑H300, code 02258‑000002, in the communication category. It gives July 2026 as the release month, so the new announcement concerns classification rather than the robot’s initial launch.

A facility comparing a listing with a quotation can begin with the identifier, not just the product family name. The registry entry and the offered equipment need to refer to the same item before a buyer can sensibly discuss what the classification means for its proposed purchase. A similar name or an older model is not enough to establish that match.

That document check also keeps different claims apart. An equipment classification describes the listed product and category. Whether a particular facility can obtain funding depends on the application and applicable program conditions. The announcement alone is not confirmation that an institution has received an award.

Specify the task before evaluating the robot

For a facility considering a communication robot, a useful demonstration begins with the activity it wants to support. A reception interaction, a group activity and a remote conversation involve different participants and circumstances. A buyer can describe the intended setting and ask the provider to show the proposed workflow rather than infer suitability from the category label alone. The questions can be concrete: who starts the interaction, which staff member assists when it does not proceed as expected, and what the participant is meant to do next? A demonstration can then be assessed against that stated task. These are prospective evaluation questions, not observations from a Kebbi3 trial. The listing should not be turned into evidence that the robot improves clinical outcomes, replaces staff or works safely for every participant. The retained announcement and registry describe the product and its classification; OpenTools has not tested a care workflow or reviewed a clinical evaluation.

Include connectivity and service terms in the purchase discussion

The [registry](https://www.techno‑tais.jp/ServiceWelfareGoodsDetail.php?RowNo=0&YouguCode1=02258&YouguCode2=000002&ViewType=1) says an internet connection is required. It also notes different monthly arrangements for institutional and home use and describes a one‑year contract basis with annual renewal; details require an inquiry. For an operational plan, the device and its continuing service arrangement belong in the same discussion. A facility can identify where it expects the robot to operate, who manages the connection and which provider handles service questions. That gives the supplier a defined setting to assess without treating a product listing as an installation plan. Marubun also says [sales of the older Kebbi Air‑S model will end in December 2026](https://prtimes.jp/main/html/rd/p/000000142.000166754.html). That statement concerns sales; the release does not establish a support‑termination date for existing units. Someone comparing an older unit with Kebbi3 therefore needs the proposed model, service arrangement and transition information in writing. This report describes the current announcement and registry entry, not local subsidy eligibility or legal advice. No application, purchase, account or device test was performed. Official Kebbi3 product image supplied by Marubun via [PR TIMES](https://prtimes.jp/main/html/rd/p/000000142.000166754.html). Cropped to show the robot’s head and upper body; it is not a care trial, a clinical result or evidence of a funding award. Used for editorial reporting under [PR TIMES reporting terms](https://prtimes.jp/main/html/kiyaku).

Share this article

PostShare

Related News